Technology

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

Afton Scientific will deepen its roots in Central Virginia with the assistance of a Youngkin-approved grant from the Commonwealth's Development Opportunity Fund.

AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

Much of the industry's success wouldn't be possible without the talent that comes out of UVA, which has developed various ways to support researchers.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

The UVA Center for Engineering in Medicine promotes innovation by embedding engineering students into clinical environments and nursing and medical trainees into engineering laboratories.

NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.